Has John Burkins received payments from drug or device companies?

Yes. Drug and device makers reported $6,252 in general payments to John Burkins across 198 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Burkins did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Burkins come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Burkins

Psychiatry · Bethlehem, PANPI 1811971864

Payments from drug & device makers

$6,252in general payments, 2019–2025

Across 198 payments — averaging $31.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teva Pharmaceuticals USA, Inc.$2K
Neurocrine Biosciences, Inc.$1K
Alkermes, Inc.$1K
Johnson & Johnson$905
Otsuka America Pharmaceutical, Inc.$403
E.r. Squibb & Sons, L.L.C.$229
plus $536 from 5 others

What the payments were for

Food & beverage$6,04697%
Education$2073%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teva Pharmaceuticals USA, Inc.	70	$1,990
Neurocrine Biosciences, Inc.	33	$1,147
Alkermes, Inc.	22	$1,041
Johnson & Johnson	34	$905
Otsuka America Pharmaceutical, Inc.	21	$403
E.r. Squibb & Sons, L.L.C.	6	$229
Vanda Pharmaceuticals Inc.	4	$189
AbbVie	3	$170
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$150
Almatica Pharma LLC	1	$15
Lundbeck LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,252 in reported general payments places this provider in the 90th percentile of 1,838 psychiatry providers in Pennsylvania.

See all psychiatry providers in Pennsylvania →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
IngrezzaValbenazine Tosylate	65	$549,368
Invega SustennaPaliperidone Palmitate	49	$174,250
VraylarCariprazine Hcl	54	$71,278
LybalviOlanzapine/Samidorphan Malate	13	$20,181
Clozapine	272	$16,667
Divalproex Sodium ErDivalproex Sodium	98	$5,038
Fluphenazine Hcl	53	$3,610
Lamotrigine ErLamotrigine	13	$3,571
Haloperidol Decanoate	60	$2,661
VascepaIcosapent Ethyl	13	$2,113
Aripiprazole	71	$1,834
Atomoxetine Hcl	37	$1,502
Olanzapine	136	$1,270
Doxepin Hcl	71	$1,254
Carbamazepine	42	$1,131

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza	$1,147	$549,36865 claims
Johnson & JohnsonInvega Sustenna	$905	$174,25049 claims
AbbVieVraylar	$170	$71,27854 claims
Alkermes, Inc.Lybalvi	$1,041	$20,18113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,838 psychiatry providers in Pennsylvania.

Other psychiatry in Bethlehem

Abel GonzalezBethlehem$74K
Cherian VergheseNorristown$16.3M
Steven ArnoldPhiladelphia$4.1M
Paul GrossAllentown$4.1M
Shivkumar HattiMedia$4M
Rebecca RomaPittsburgh$3.3M
Matthew BergerMoosic$2.4M
Michael ThasePhiladelphia$2.2M
Robert NelsonWyomissing$2.2M
Mark MattaNew Castle$847K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →